Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-059728
Filing Date
2021-10-05
Accepted
2021-10-05 19:49:37
Documents
2
Period of Report
2021-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1613
2 POA DOCUMENT poa.txt EX-24.3_1012036 3430
  Complete submission text file 0001209191-21-059728.txt   6403
Mailing Address C/O TRANSUNION 555 WEST ADAMS STREET CHICAGO IL 60661
Business Address
Hamood Samuel A (Reporting) CIK: 0001645772 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40227 | Film No.: 211308415

Mailing Address 200 INNER BELT ROAD SOMERVILLE MA 02143
Business Address 200 INNER BELT ROAD SOMERVILLE MA 02143 617-229-6499
Finch Therapeutics Group, Inc. (Issuer) CIK: 0001733257 (see all company filings)

EIN.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)